Implications of genomics for public health: The role of genetic epidemiology

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 68, Issue , 2003, Pages 359-364

  Merikangas, K R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CONFIDENTIALITY; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENETIC EPIDEMIOLOGY; GENOMICS; HUMAN; POPULATION GENETICS; PRIORITY JOURNAL; PUBLIC HEALTH; RNA TRANSLATION; ARTICLE; ATTITUDE TO HEALTH; COMPREHENSION; EPIDEMIOLOGIST; ETHICIST; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOTYPE ENVIRONMENT INTERACTION; HEALTH BEHAVIOR; HEALTH CARE PERSONNEL; HUMAN GENOME; MAJOR GENE; MALIGNANT NEOPLASM; PROBABILITY; RISK FACTOR; SCIENTIST; SINGLE NUCLEOTIDE POLYMORPHISM; STUDY DESIGN;

EID: 3242728392     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2003.68.359     Document Type: Conference Paper

References (55)

1. ACS. 2003. Cancer facts and figures 2003, p. 1. American Cancer Society, Atlanta, Georgia.
2. Akerblom H.K., Vaarala O., Hyoty H., Ilonen J., and Knip M. 2002. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115: 18.
3. Alexander D.R. 2003. Uses and abuses of genetic engineering. Postgrad. Med. J. 79: 249.
4. Altmuller J., Palmer L.J., Fischer G., Scherb H., and Wjst M. 2001. Genomewide scans of complex human diseases: True linkage is hard to find. Am. J. Hum. Genet. 69: 936.
5. Dick D.M., Rose R.J., Viken R.J., Kaprio J., and Koskenvuo M. 2001. Exploring gene-environment interactions: Socioregional moderation of alcohol use. J. Abnorm. Psychol. 110: 625.
6. Ellsworth D.L. and Manolio T.A. 1999a. The emerging importance of genetics in epidemiologic research. II. Issues in study design and gene mapping. Ann. Epidemiol. 9: 75.
7. -. 1999b. The emerging importance of genetics in epidemiologic research. III. Bioinformatics and statistical genetic methods. Ann. Epidemiol. 9: 207.
8. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278: 1349.
9. Foppa I. and Spiegelman D. 1997. Power and sample size calculations for case-control studies of gene-environment interactions with a polytomous exposure variable. Am. J. Epidemiol. 146: 596.
10. Garcia-Closas M. and Lubin J.H. 1999. Power and sample size calculations in case-control studies of gene-environment interactions: Comments on different approaches. Am. J. Epidemiol. 149: 689.
11. Glazier A.M., Nadeau J.H., and T.J. Aitman T.J. 2002. Finding genes that underlie complex traits. Science 298: 2345.
12. Gordis L. 2000. Epidemiology. W.B. Saunders, Philadelphia, Pennsylvania.
13. Guttmacher A.E. and Collins F.S. 2002. Genomic medicine - A primer. N. Engl. J. Med. 347: 1512.
14. Hanley A.J., Choi B.C., and Holowaty E.J. 1995. Cancer mortality among Chinese migrants: A review. Int. J. Epidemiol. 24: 255.
15. Heath A.C., Whitfield J.B., Madden P.A., Bucholz K.K., Dinwiddie S.H., Slutske W.S., Bierut L.J., Statham D.B., and Martin N.G. 2001. Towards a molecular epidemiology of alcohol dependence: Analysing the interplay of genetic and environmental risk factors. Br. J. Psychiatry (suppl.) 40: s33.
16. Hirschhorn J.N., Lohmueller K., Byrne E., and Hirschhorn K. 2002. A comprehensive review of genetic association studies. Genet. Med. 4: 45.
17. Human Genome Project Information. 2003. Ethical, legal, and social issues: http://www.oml.gov/sci/techresources/Human_Genome/elsi/elsi.shtml
18. Hwang S.J., Beaty T.H., Liang K.Y., Coresh J., and Khoury M.J. 1994. Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am. J. Epidemiol. 140: 1029.
19. Kenny S.J., Aubert R.E., and Geiss L.S. 1995. Prevalence and incidence of non-insulin-dependent diabetes. In Diabetes in America, 2nd edition, p. 47. National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468.
20. Khoury, M.J. 1998. Genetic epidemiology. In Modern epidemiology, 2nd edition (ed. K.J. Rothman and S. Greenland), p. 609. Lippincott-Raven, Philadelphia, Pennsylvania.
21. Khoury M.J. and Yang Q. 1998. The future of genetic studies of complex human disease. An epidemiologic perspective. Epidemiology 9: 350.
22. Khoury M.J., Beaty T.H., and Cohen B.H. 1993. Fundamentals of genetic epidemiology. Oxford University Press, New York.
23. Khoury M.J., McCabe L.L., and McCabe E.R. 2003. Population screening in the age of genomic medicine. N. Engl. J. Med. 348: 50.
24. King M.C., Lee G.M., Spinner N.B., Thomson G., and Wrensch M.R. 1984. Genetic epidemiology. Annu. Rev. Public Health 5: 1
25. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., and Nissinen A. 2001. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. Br. Med. J. 322: 1447.
26. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., Iivonen S., Mannermaa A., Tuomilehto J., Nissinen A., and Soininen H. 2002. Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann. Intern. Med. 137: 149.
27. Knoller W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., and Nathan D.M. 2002. Diabetes Prevention Research Group. Reduction in the incidence of type II diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346: 393.
28. Langholz B., Rothman N., Wacholder S., and Thomas D.C. 1999. Cohort studies for characterizing measured genes. J. Natl. Cancer Inst. Monogr. 26: 39.
29. Merikangas K.R. 2002. Genetic epidemiology: Bringing genetics to the population - The NAPE Lecture 2001. Acta Psychiatr. Scand. 105: 3.
30. Merikangas K.R. and Risch N. 2003. Genomic priorities and public health. Science 302: 599.
31. Merikangas K.R., Chakravarti A., Moldin S.O., Araj H., Blangero J., Burmeister M., Crabbe J.C.J., DePaulo J.R.J., Foulks E., Freimer N.B., Koretz D.S., Lichtenstein W., Mignot E., Reiss A.L., Risch N.J., and Takahashi J. 2002. Future of genetics of mood disorders research: Workgroup on genetics for NIMH strategic plan for mood disorders. Biol. Psychiatry 52: 457.
32. Michael N.L. 1999. Host genetic influences on HIV-1 pathogenesis. Curr. Opin. Immunol. 11: 466.
33. Munoz D.G. and Feldman H. 2000. Causes of Alzheimer's disease. Can. Med. Assoc. J. 162: 65.
34. Nebert D.W., Ingelman-Sundberg M., and Daly A.K. 1999. Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Drug Metab. Rev. 31: 467.
35. Ottman R. 1990. An epidemiologic approach to gene-environment interaction. Genet. Epidemiol. 7: 177.
36. Ravussin E., Valencia M.E., Esparza J., Bennett P.H., and Schulz L.O. 1994. Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 17: 1067.
37. Renegar G., Rieser P., and Manasco P. 2001. Family consent and the pursuit of better medicines through genetic research. J. Contin. Educ. Health Prof 21: 265.
38. Rewers M.R. and Hamman R.F. 1995. Risk factors for non-insulin-dependent diabetes. In Diabetes in America, 2nd edition, p. 179. National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468.
39. Risch N. 1990. Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 46: 222.
40. -. 2000. Searching for genetic determinants in the new millenium. Nature 405: 847.
41. -. 2001. The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol. Biomark. Prev. 10: 733.
42. Risch N. and Merikangas K.R. 1996. The future of genetic studies of complex human diseases. Science 273: 1516.
43. Sadovnick A.D. 2002. The genetics of multiple sclerosis. Clin. Neurol. Neurosurg. 104: 199.
44. Shaper A.G. and Elford J. 1991. Place of birth and adult cardiovascular disease: The British Regional Heart Study. Acta Paediatr. Scand. Suppl. 373: 73.
45. Slooter A. and van Duijn C. 1997. Genetic epidemiology of Alzheimer disease. Epidemiol. Rev. 19: 107.
46. Smith P.G. and Day N.E. 1984. The design of case-control studies: The influence of confounding and interaction effects. Int. J. Epidemiol. 13: 356.
47. Sobngwi E., Boudou P., Mauvais-Jarvis F., Leblanc H., Velho G., Vexiau P., Porcher R., Hadjadj S., Pratley R., Tataranni P.A., Calvo F., and Gautier J.-F. 2003. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 361: 1861.
48. Thomas D.C. 2000. Genetic epidemiology with a capital "E". Genet. Epidemiol. 19: 289.
49. Tol J., Roks G., Slooter A.J., and van Duijn C.M. 1999. Genetic and environmental factors in Alzheimer's disease. Rev. Neurol. (suppl. 4) 155: S10.
50. Trevisan R., Vedovato M., and Tiengo A. 1998. The epidemiology of diabetes mellitus. Nephrol. Dial. Transplant. (suppl. 8) 13: 2.
51. Wacholder S., Chatterjee N., and Hartge P. 2002. Joint effect of genes and environment distorted by selection biases: Implications for hospital-based case-control studies. Cancer Epidemiol. Biomark. Prev. 11: 885.
52. Weiss R. 2003. Science Notebook, May 19, p. 7. In The Washington Post, Washington, D.C.
53. WHO. 2002. Reducing risks, promoting healthy life. In World Health Report 2002: Preventing risks and taking action, chapter 7. World Health Organization.
54. Yang Q. and Khoury M.J. 1997. Evolving methods in genetic epidemiology III. Gene-environment interaction in epidemiologic research. Epidemiol. Rev. 19: 33.
55. Yang Q., Khoury M.J., Coughlin S.C., Sun F., and Flanders W.D. 2000. On the use of population-based registries in the clinical validation of genetic tests for disease susceptibility. Genet. Med. 2: 186.